What is the address of Dr. Loretta Tadevosian, huisarts?

The registered office of Dr. Loretta Tadevosian, huisarts is located at Nijverheidslaan 35, 3290 Diest.

Is Dr. Loretta Tadevosian, huisarts still active?

Yes. According to the CBE (27 September 2026) Dr. Loretta Tadevosian, huisarts is active, legal situation “Normale toestand”, started on 17 April 2018.

Is Dr. Loretta Tadevosian, huisarts registered on Peppol?

No, Dr. Loretta Tadevosian, huisarts is currently not registered on the Peppol network.

What is the enterprise number of Dr. Loretta Tadevosian, huisarts?

The enterprise number of Dr. Loretta Tadevosian, huisarts is BE0694802882.

When was Dr. Loretta Tadevosian, huisarts founded?

Dr. Loretta Tadevosian, huisarts was founded on 17 April 2018.

Who are the directors of Dr. Loretta Tadevosian, huisarts?

According to the 2025 annual accounts, the directors of Dr. Loretta Tadevosian, huisarts are: LORETTA TADEVOSIAN.

Is Dr. Loretta Tadevosian, huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Loretta Tadevosian, huisarts make in 2025?

Dr. Loretta Tadevosian, huisarts posted a profit after taxes of € 51,519 in financial year 2025.

What is the revenue of Dr. Loretta Tadevosian, huisarts?

As a small company, Dr. Loretta Tadevosian, huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 136,112.

Dr. Loretta Tadevosian, huisarts (Private Limited)

Dossier Dr. Loretta Tadevosian, huisarts, printed on 27 September 2026 from databakkes.be/en/0694802882/dr-loretta-tadevosian-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Loretta Tadevosian, huisarts from Diest, company number BE0694802882, closed financial year 2025 with a result of € 51,519 after tax. For that financial year Dr. Loretta Tadevosian, huisarts recorded a gross margin of € 136,112 and equity of € 157,654. Compared with financial year 2024, the result moved from € 44,331 to € 51,519. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 157,654

▲ 49% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 51,519

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 102,174

▲ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 145,254.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 245

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 35,691

▼ 38% vs 2024

€ 21,631 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 326

▲ 116% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 54,980

▲ 215% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 117,268 Gross margin 2022: € 117,268 First fiscal year in the series	€ 109,594 Gross margin 2023: € 109,594 ▼ 7% vs 2022 (€ 117,268) Unfavourable step	€ 102,059 Gross margin 2024: € 102,059 ▼ 7% vs 2023 (€ 109,594) Unfavourable step	€ 136,112 Gross margin 2025: € 136,112 ▲ 33% vs 2024 (€ 102,059) Favourable step	▲ 33%
Profit after taxes	€ -77,854 Profit after taxes 2022: € -77,854 First fiscal year in the series	€ 44,211 Profit after taxes 2023: € 44,211 ▲ € 122,064 vs 2022 (€ -77,854) Favourable step	€ 44,331 Profit after taxes 2024: € 44,331 Unchanged (€ 44,211) Favourable step	€ 51,519 Profit after taxes 2025: € 51,519 ▲ 16% vs 2024 (€ 44,331) Favourable step	▲ 16%
Equity	€ 17,594 Equity 2022: € 17,594 First fiscal year in the series	€ 61,805 Equity 2023: € 61,805 ▲ 251% vs 2022 (€ 17,594) Favourable step	€ 106,136 Equity 2024: € 106,136 ▲ 72% vs 2023 (€ 61,805) Favourable step	€ 157,654 Equity 2025: € 157,654 ▲ 49% vs 2024 (€ 106,136) Favourable step	▲ 49%
Total debts	€ 155,082 Total debts 2022: € 155,082 First fiscal year in the series	€ 98,995 Total debts 2023: € 98,995 ▼ 36% vs 2022 (€ 155,082) Favourable step	€ 76,662 Total debts 2024: € 76,662 ▼ 23% vs 2023 (€ 98,995) Favourable step	€ 90,997 Total debts 2025: € 90,997 ▲ 19% vs 2024 (€ 76,662) Unfavourable step	▲ 19%
Cash	€ 68,709 Cash 2022: € 68,709 First fiscal year in the series	€ 56,149 Cash 2023: € 56,149 ▼ 18% vs 2022 (€ 68,709) Unfavourable step	€ 73,197 Cash 2024: € 73,197 ▲ 30% vs 2023 (€ 56,149) Favourable step	€ 102,174 Cash 2025: € 102,174 ▲ 40% vs 2024 (€ 73,197) Favourable step	▲ 40%
Land & buildings	€ 7,300 Land & buildings 2022: € 7,300 First fiscal year in the series	€ 29,666 Land & buildings 2023: € 29,666 ▲ € 22,366 vs 2022 (€ 7,300) Unchanged	€ 26,369 Land & buildings 2024: € 26,369 ▼ 11% vs 2023 (€ 29,666) Unchanged	€ 24,108 Land & buildings 2025: € 24,108 ▼ 9% vs 2024 (€ 26,369) Unchanged	▼ 9%
Retained profit	€ 5,194 Retained profit 2022: € 5,194 First fiscal year in the series	€ 49,405 Retained profit 2023: € 49,405 ▲ € 44,211 vs 2022 (€ 5,194) Favourable step	€ 93,736 Retained profit 2024: € 93,736 ▲ 90% vs 2023 (€ 49,405) Favourable step	€ 145,254 Retained profit 2025: € 145,254 ▲ 55% vs 2024 (€ 93,736) Favourable step	▲ 55%
Bank debt	€ 109,403 Bank debt 2022: € 109,403 First fiscal year in the series	€ 82,236 Bank debt 2023: € 82,236 ▼ 25% vs 2022 (€ 109,403) Favourable step	€ 57,322 Bank debt 2024: € 57,322 ▼ 30% vs 2023 (€ 82,236) Favourable step	€ 35,691 Bank debt 2025: € 35,691 ▼ 38% vs 2024 (€ 57,322) Favourable step	▼ 38%
Balance sheet total	€ 172,676 Balance sheet total 2022: € 172,676 First fiscal year in the series	€ 160,800 Balance sheet total 2023: € 160,800 ▼ 7% vs 2022 (€ 172,676) Unchanged	€ 182,798 Balance sheet total 2024: € 182,798 ▲ 14% vs 2023 (€ 160,800) Unchanged	€ 248,651 Balance sheet total 2025: € 248,651 ▲ 36% vs 2024 (€ 182,798) Unchanged	▲ 36%

Key figures of Dr. Loretta Tadevosian, huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Loretta Tadevosian, huisarts?

What happened at Dr. Loretta Tadevosian, huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 51,519 (▲ 16% vs 2024). Source: NBB ↗
Apr 17, 2018 New establishment in Diest. KBO
2018 LORETTA TADEVOSIAN became a director. NBB
Apr 17, 2018 Start of the company according to the CBE. KBO

In short

From € 77,854 loss in 2022 to € 51,519 profit in 2025.

Paid € 129,230 in corporate taxes since 2022.

Best year ever: 2025, with € 51,519 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Loretta Tadevosian, huisarts? We notify you, reason included.

Follow Dr. Loretta Tadevosian, huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LORETTA TADEVOSIAN

Dr. Loretta Tadevosian, huisarts

Behind Dr. Loretta Tadevosian, huisarts is LORETTA TADEVOSIAN.

See the full network in the app

Directors

According to the 2025 annual accounts

LORETTA TADEVOSIAN

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Nijverheidslaan 35

3290 Diest

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0694.802.882
VAT number: BE 0694.802.882
Registered office: Nijverheidslaan 35, 3290 Diest
Names & denominations: Dr. Loretta Tadevosian, huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 April 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗